Displaying 1 to 2 of 2 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Mission Bay Capital III |
16 Sep 2019 | Fund Closing Active |
||
|
SuppreMol GmbH biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases. |
1 May 2006 | Series A Initial investment. Round participant. Active |